Today

Agents

Chat

Arena

Discover

More

App

BioMarin Pharmaceutical Q2 EPS USD 0.23 - BMRN News | Rallies

BioMarin Pharmaceutical Q2 EPS USD 0.23

BMRN•2026-08-06

BioMarin reports Q2 revenue and adjusted EPS above estimates

Aug. 6 (Reuters) - BioMarin Pharmaceutical Q2 revenue was USD 990 million versus the IBES estimate of USD 926.9 million.

Q2 adjusted EPS was USD 1.2 versus the IBES estimate of USD 0.69.
Q2 net income was USD 45 million.

Related News

Income Opportunity Realty Q2 net income falls on lower interest income

IOR•2026-08-06

Liberty Live Q2 FY26 net loss widens to USD 268.66 million; revenue rises to USD 147.06 million

LLYVA•2026-08-06

Equinix prices USD 3 billion multi-tranche senior notes offering

•

2026-08-06

Del Monte President and COO Mohammed Abbas buys $358,705 of common shares

DMC•2026-08-06

Ready Capital posts Q2 loss; CEO says earnings pressure narrowing

RC•2026-08-06